The majority of patients were women (76.6%) and the average age at diagnosis was 51.3 years. The average cancer size was 1.6 cm and two-thirds of the cancers with recurrent laryngeal nerve invasion were 1.5-2.0 cm. In addition to the invasion of the recurrent laryngeal nerve, invasion into the trachea, esophagus, fibroadipose tissue, strap muscles, and larynx was seen in 15 (50%), 12 (40%), 4 (13.3%), 3 (10.0%), and 3 (10%) patients, respectively. Imaging before surgery showed invasion of the recurrent laryngeal nerve in only 8 patients (26.7%). In 29 out of 30 patients, the primary cancer was on the inner side of the thyroid next to the trachea. However, the overall risk of involvement of structures in the neck beyond the thyroid gland with these cancers was low. This was especially true for tumors that were very small, that is less than 9 mm in size.
WHAT ARE THE IMPLICATIONS OF THIS STUDY?
This study showed that patients with thyroid cancers that are next to the trachea are not appropriate candidates for active surveillance. Moreover, only one-fourth of the patients had findings on imaging before surgery suggesting extension of the cancer beyond the capsule and invading other structures. It is encouraging that invasion of the recurrent laryngeal nerve was not observed for cancers smaller than 0.9 cm regardless of cancer location.
These findings are important to guide physicians and patients when discussing different management options for small thyroid cancers, including active surveillance. In addition to the cancer size and growth rate, the cancer’s location in respect to the trachea and the recurrent laryngeal nerve should be considered in decision-making. It is also important for patients to have high-quality imaging and an experienced multidisciplinary team to carefully interpret findings, before considering active surveillance.
— Maria Papaleontiou, MD and Vibhavasu Sharma, MD, FACE